blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4196544

EP4196544 - SILICONE FORMULATION COMPRISING AN OXIME CROSSLINKER, CURED SILICONE FORMULATION AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  15.03.2024
Database last updated on 06.11.2024
FormerRequest for examination was made
Status updated on  19.05.2023
FormerThe international publication has been made
Status updated on  21.02.2022
Formerunknown
Status updated on  07.09.2021
Most recent event   Tooltip13.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Soudal N.V.
Everdongenlaan 20
2300 Turnhout / BE
[2023/25]
Inventor(s)01 / GEBOES, Peter
2630 Aartselaar / BE
02 / WOUTERS, Dominique
2275 Gierle / BE
03 / DE BACKER, Evelien
2580 Putte / BE
 [2023/25]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2023/25]
Application number, filing date21762419.611.08.2021
[2023/25]
WO2021EP72381
Priority number, dateEP2020019086213.08.2020         Original published format: EP 20190862
[2023/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022034138
Date:17.02.2022
Language:EN
[2022/07]
Type: A1 Application with search report 
No.:EP4196544
Date:21.06.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 17.02.2022 takes the place of the publication of the European patent application.
[2023/25]
Search report(s)International search report - published on:EP17.02.2022
ClassificationIPC:C09J183/04, C08L83/04
[2023/25]
CPC:
C08L83/04 (EP,KR); C08G77/16 (EP,KR,US); C08G77/08 (US);
C08G77/388 (US); C08K3/36 (US); C08K5/0025 (KR);
C08K5/5419 (US); C08K5/5465 (KR,US); C08K5/57 (KR);
C09J183/04 (EP,KR,US); C08G2170/00 (US); C08G2190/00 (US);
C08K2201/014 (US) (-)
C-Set:
C08L83/04, C08K5/5465, C08K5/5465, C08K5/57, C08L83/00 (EP);
C09J183/04, C08K5/5465, C08K5/5465, C08K5/57, C08L83/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/25]
TitleGerman:SILIKONFORMULIERUNG MIT EINEM OXIMVERNETZER, GEHÄRTETE SILIKONFORMULIERUNG UND VERWENDUNGEN DAVON[2023/25]
English:SILICONE FORMULATION COMPRISING AN OXIME CROSSLINKER, CURED SILICONE FORMULATION AND USES THEREOF[2023/25]
French:FORMULATION DE SILICONE COMPRENANT UN AGENT DE RÉTICULATION À BASE D'OXIME, FORMULATION DE SILICONE DURCIE ET UTILISATIONS ASSOCIÉES[2023/25]
Entry into regional phase28.02.2023National basic fee paid 
28.02.2023Designation fee(s) paid 
28.02.2023Examination fee paid 
Examination procedure28.02.2023Examination requested  [2023/25]
28.02.2023Date on which the examining division has become responsible
05.09.2023Amendment by applicant (claims and/or description)
19.03.2024Despatch of a communication from the examining division (Time limit: M04)
15.04.2024Reply to a communication from the examining division
Fees paidRenewal fee
31.08.2023Renewal fee patent year 03
13.08.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US5359108  (MATHEW CHEMPOLIL T [US], et al)
ExaminationUS5534588
 US6413354
by applicantUS5359108
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.